ARCHIVES

In Brief: Robert Bast Succeeds Singleton As Director Of Duke Cancer Center; Robert Bell Deputy

This article is from The Cancer Letter archive.

Vol. 13 No. 33 | August 14, 1987

Download PDF Visit The Full Archive

Related Articles

Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival

April 25, 2014

In Brief: Last Bit of Nonsense By Weinberger; Magnuson May Write NCI Positions Into HEW Money Bill

July 18, 1975

In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs

November 27, 1998

In Brief: Taxol Development Is NCI ‘Emergency Priority’, Dodd To Focus ACS Effort On Breast Screening

December 7, 1990

Aflibercept-Docetaxel Combination Misses Primary Survival Endpoint

March 25, 2011

FDA News: Avastin Combination Approved In Recurrent Ovarian Cancer

November 14, 2014